MerLion Pharmaceuticals
Manufacturing · Germany · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Robert-rössle-straße 10, Berlin, Berlin,...Phone Number
+49 3094894050Website
www.merlionpharma.comRevenue
$6.4 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About MerLion Pharmaceuticals
MerLion Pharmaceuticals is a privately-held biopharmaceutical company headquartered in Berlin, Germany. The company focuses on the advanced clinical development of its antibacterial lead program, finafloxacin.Explore more
MerLion Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is MerLion Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once MerLion Pharmaceuticals has new funding data
Check if MerLion Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if MerLion Pharmaceuticals is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at MerLion Pharmaceuticals
Earning: See what the market has to say on MerLion Pharmaceuticals recently announced quarterly report
Product Launch: Get notified when MerLion Pharmaceuticals launches new products
Click to see if MerLion Pharmaceuticals had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
MerLion Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Find VP level buyers at MerLion Pharmaceuticals
Find more new buyers
Company Profile Activity
Activity Insights
MerLion Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
MerLion Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about MerLion Pharmaceuticals.
MerLion Pharmaceuticals financials insights
Gather financial insights about MerLion Pharmaceuticals, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2002
Series A
$13.5M
2010
Series B
$7M
MerLion Pharmaceuticals Tech Stack
A closer look at the technologies used by MerLion Pharmaceuticals
See more technologies
MerLion Pharmaceuticals News & Media
MerLion Regains North American Rights to XTOROTM FDA-Approved Antibiotic for Treatment of Ear Infections
SINGAPORE--(BUSINESS WIRE)--MerLion announces Novartis has terminated the license between Alcon and MerLion executed in 2010 and returned all XTORO rights to MerLion.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding MerLion Pharmaceuticals
Sign Up For FreeTo access detailed company insights
MerLion Pharmaceuticals is a privately-held biopharmaceutical company headquartered in Berlin, Germany. The company focuses on the advanced clinical development of its antibacterial lead program, finafloxacin.... Read More
